Syfovre Approved for the Treatment of GA, a form of Dry Age-Related Macular Degeneration (AMD)
Автор: DOCTOR RETINA
Загружено: 2023-02-17
Просмотров: 8940
Syfovre is a new medication that was approved by the FDA today for the treatment of a type of eye disease called geographic atrophy (GA). GA is caused by dry-type age-related macular degeneration (AMD), which can lead to blindness. Syfovre works by blocking some proteins in the body that are involved in inflammation and damage to the eye.
GA is a condition that affects the retina, which is the part of the eye that helps you see. GA occurs when some cells in the retina die, leaving patches that look different from the rest. GA is usually caused by AMD, which is a common eye problem that happens as people get older. GA can lead to vision loss over time and make it hard to do daily tasks like reading or driving.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
